News

The global RNA therapeutics and vaccines market is projected to reach USD 940 million by 2035, growing at a CAGR of 68%. This ...
Moderna (NASDAQ:MRNA) has cancelled plans to build a messenger RNA manufacturing plant in Japan, citing concerns over the ...
DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...
Guoping Li, Ph.D., of the Department of Anesthesia, Critical Care & Pain Medicine at Massachusetts General Hospital, is the ...
How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...
A specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumors ...
A new study by researchers at Bar-Ilan University has uncovered that certain ocean viruses—specifically RNA viruses—may ...
Whole transcriptome sequencing RNA library preparation gets a boost from the latest automated liquid handling technology.
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
Linked to neurological disorders, repeat RNAs aggregate inside droplets but can be disassembled with an engineered piece of ...
Once dismissed as “junk,” a group of RNA molecules has been found to help regrow damaged nerves in mice in new research. The ...
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and  Scripps Research, the ...